Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES.
Morillas P, Pallarés V, Llisterri JL, Sanchis C, Sánchez T, Fácila L, Pérez-Alonso M, Castillo J, Redón J, Bertomeu V; en representación de los investigadores del registro FAPRES. Morillas P, et al. Among authors: pallares v. Rev Esp Cardiol. 2010 Aug;63(8):943-50. doi: 10.1016/S0300-8932(10)70206-2. Epub 2010 Sep 16. Rev Esp Cardiol. 2010. PMID: 23020978 Free article. English, Spanish.
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial.
Morillas P, Pallarés V, Llisterri JL, Sanchis C, Sánchez T, Fácila L, Pérez-Alonso M, Castillo J, Redón J, Bertomeu V; FAPRES RegistryResearchers. Morillas P, et al. Among authors: pallares v. Rev Esp Cardiol. 2010 Aug;63(8):943-50. doi: 10.1016/s1885-5857(10)70188-2. Rev Esp Cardiol. 2010. PMID: 20738939 Free article. English, Spanish.
The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older.
Morillas P, Pallarés V, Fácila L, Llisterri JL, Sebastián ME, Gómez M, Castilla E, Camarasa R, Sandin M, García-Honrubia A; FAPRES registry investigators. Morillas P, et al. Among authors: pallares v. Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):485-91. doi: 10.1016/j.rec.2014.06.027. Epub 2014 Dec 2. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25487320
[In the identification of cardiovascular risk with the SCORE model, could we recommend its calculation interchangeably with total cholesterol or atherogenic index? Concordance between total cholesterol and atherogenic index in the SCORE table].
Gil-Guillén VF, Orozco-Beltrán D, Pita-Fernández S, Carratalá-Munuera C, Redón J, Navarro J, Pallarés V, Pertusa S. Gil-Guillén VF, et al. Among authors: pallares v. Rev Esp Cardiol. 2011 May;64(5):421-3. doi: 10.1016/j.recesp.2010.06.001. Epub 2011 Mar 11. Rev Esp Cardiol. 2011. PMID: 21397378 Free article. Spanish.
Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM; ESCARVAL Study Group. Redon J, et al. Among authors: pallares v. J Hypertens. 2016 Jun;34(6):1075-83. doi: 10.1097/HJH.0000000000000930. J Hypertens. 2016. PMID: 27074896
107 results